Losartan for the nephropathy of sickle cell anemia: A phase‐2, multicenter trial - Quinn, Charles T.; Saraf, Santosh L.; Gordeuk, Victor R.; Fitzhugh, Courtney D.; Creary, Susan E.; Bodas, Prasad; George, Alex; Raj, Ashok B.; Nero, Alecia C.; Terrell, Catherine E.; McCord, Lisa; Lane, Adam; et al. (American journal of hematology, 2017)
Keywords: Adolescent; Adult; Age Factors; Albumin; Albuminuria - drug therapy; Albuminuria - etiology; Albuminuria - physiopathology; Albuminuria - urine; Anemia; Anemia, Sickle Cell - complications; Anemia, Sickle Cell - drug therapy; Anemia, Sickle Cell - physiopathology; Anemia, Sickle Cell - urine; Angiotensin; Angiotensin II; Child; Creatinine; Epidermal growth factor receptors; Excretion; Female; Glomerular Filtration Rate; Humans; Losartan - administration & dosage; Male; Middle Aged; Nephropathy; Rodents; Sickle cell anemia; Sickle cell disease; Urine